Atrial Fibrillation and Heart Failure as the Onset of AL-Amyloidosis

Left ventricular hypertrophy, atrial fibrillation and chronic heart failure are often in the practice of a cardiologist. The etiology of these conditions is very important because the correct early treatment. We are presenting a case of a late diagnosis of amyloidosis in a 53-year-old man. Despite t...

Full description

Saved in:
Bibliographic Details
Published inArkhivʺ vnutrenneĭ medit͡s︡iny Vol. 11; no. 6; pp. 457 - 465
Main Authors Reznik, E. V., Lazarev, V. A., Borisovskay, S. V., Golukhov, G. N.
Format Journal Article
LanguageEnglish
Russian
Published SINAPS LLC 29.11.2021
Subjects
амилоидная кардиомиопатия
амилоидоз сердца
гипертрофия левого желудочка
кардиоренальный синдром
нефротический синдром
протеинурия
фибрилляция предсердий
хроническая болезнь почек
хроническая сердечная недостаточность с сохраненной фракцией выброса левого желудочка
Online AccessGet full text

Cover

More Information
Summary:Left ventricular hypertrophy, atrial fibrillation and chronic heart failure are often in the practice of a cardiologist. The etiology of these conditions is very important because the correct early treatment. We are presenting a case of a late diagnosis of amyloidosis in a 53-year-old man. Despite the complex therapy, the course of the disease was complicated by the development of bilateral pneumonia, sepsis, disseminated intravascular coagulation and the patient died. Autopsy confirmed the diagnosis of systemic AL-amyloidosis (type Kappa) with massive damage to the heart, kidneys, lungs, liver, spleen, adrenal glands, thyroid gland, pancreas, gastrointestinal tract, subcutaneous fatty tissue and arterial vessels of the bone marrow. Thus, screening for amyloidosis is necessary in idiopathic LV thickening, atrial fibrillation, and heart failure for timely intravital diagnosis and therapy.
ISSN:2226-6704
2411-6564
DOI:10.20514/2226-6704-2021-11-6-457-465